Atypical Antipsychotics and Pituitary Neoplasms in the WHO Database

P. Murali Doraiswamy, MD, Gisela Schott, MD, MPH, Kristina Star, RN, Ralph Edwards, MD, and Bruno Mueller-Oerlinghausen, MD

Psychopharmacology Bulletin 40(1): 74-76, 2007/01/19; https://doi.org/10.64719/pb.4133

Abstract

Amisulpride and risperidone had among the highest Information Component (IC) scores for benign pituitary neoplasm: amisulpride (IC = 3.31, IC025 = 1.83, 5 reports) and risperidone (IC = 4.03, IC025 = 3.33, 19 reports), and not otherwise specified (NOS) pituitary neoplasm: amisulpride (IC = 2.69, IC025 = 0.70, 3 reports) and risperidone (IC = 4.49, IC025 = 3.86, 23 reports). Psychopharmacology Bulletin. 2007;40(1):74-76.

Keywords

adverse drug reaction reporting systems, antipsychotic agents, Hyperprolactinemia, pituitary neoplasms

Access This Article

Choose an access option below to view the full article.

Subscriber Access

If you or your institution has a subscription, log in to access this article.

Not yet subscribed? View subscription options

Purchase Article

Buy single-article access with a one-time purchase.

$30.00

Add to Cart

How to Cite

P. Murali Doraiswamy, MD, Gisela Schott, MD, MPH, Kristina Star, RN, Ralph Edwards, MD, and Bruno Mueller-Oerlinghausen, MD. Atypical Antipsychotics and Pituitary Neoplasms in the WHO Database. Psychopharmacology Bulletin. 2007/01/19; 40(1):74-76. https://doi.org/10.64719/pb.4133